Validación preclínica y transferencia tecnológica de nanoconjugados para terapias de reemplazo enzimático de nueva generación dirigidas a enfermedades raras
Principal Investigator:
Collaborators: Julia Lorenzo (UAB)
Agency: Ministerio de Ciencia, Innovación y Universidades
Funding:
Type of funding: Public
Period: 2026 - 2027
Pathogenic interplay between age-dependent neuromelanin accumulation and Parkinson’s disease susceptibility factors: role in the onset and progression of the disease (NeuromelaninPD)
Principal Investigator:
Miquel Vila
Agency: Spanish Ministry of Science and Innovation (MICINN, Spain)
Funding: 337,500 €
Type of funding: Public
Period: 2025 - 2028
Neuromelanin and PD: mechanisms and therapeutic perspectives
Principal Investigator:
Miquel Vila
Agency: The Michael J Fox Foundation
Funding: $500,000
Type of funding: Private
Period: 2025 - 2028
Innovació en Envelliment Saludable i Malalties Neurodegenerative (NEUROAGE)
Principal Investigator:
All
Collaborators: Del Río Fernández, José Antonio
Agency: AGAUR
Funding: 872.050 €
Type of funding: Public
Period: 2025 - 2028
GBA1 Consortium: Joint Analysis to Inform Clinical Trials (MJFF-025301)
Principal Investigator:
Marta Martinez-Vicente, Ariadna Laguna
Collaborators: Kathrin Brockmann
Agency: Michael J Fox Foundation
Funding: $1.304.737,50
Type of funding: Private
Period: 2025 - 2027
CD8 T cells and infections of the nervous system as initiators and propagators of Parkinson’s disease: towards patient stratification based on peripheral tissue biopsies
Principal Investigator:
Collaborators: Oriol De Fabregues
Agency: Instituto de Salud Carlos III
Funding: 221.250 €
Type of funding: Public
Period: 2025 - 2027
Gastrointestinal dysfunction, inflammation and synuclein pathology in Parkinson’s disease patients: potential for diagnostic and therapeutic development (PI24/00253)
Principal Investigator:
Ariadna Laguna
Agency: Instituto de Investigación Carlos III – Ministerio de Sanidad del Gobierno de España
Funding: 265.000€
Type of funding: Public
Period: 2025 - 2027
Next-generation enzyme replacement therapy for neurodegenerative and lysosomal storage diseases (2025INNOV-00005)
Principal Investigator:
Collaborators: Sebastian Tanco (UAB)
Agency: AGAUR
Funding: 84.000 €
Type of funding: Public
Period: 2025 - 2027
Validació funcional d’una nova teràpia intravenosa de reemplaçament enzimàtic per a malalties lisosomals amb afectació sistèmica i cerebral (SLT041/25/000039)
Principal Investigator:
Agency: PERIS
Funding: 148.830,00 €
Type of funding: Public
Period: 2025 - 2027
Avanzando en el manejo de la Enfermedad de Parkinson: abordando la disfunción autofágica- lisosomal para el desarrollo de herramientas innovadoras de diagnósticos y terapéuticas (PI24/00062)
Principal Investigator:
Collaborators: Jorge Hernández Vara
Agency: Instituto de Salud Carlos III
Funding: 265.000 €
Type of funding: Public
Period: 2025 - 2027